Ledger.Open graph →
SEC Form D · Amendment · filed March 18, 2021

Predictive Oncology Inc

Offering
$16.8M
Sold
$16.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EAGAN, MN
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Carl I. Schwartz · Eagan, MNExec · DirectorDaniel E. Handley · Eagan, MNDirectorRichard L. Gabriel · Eagan, MNDirectorNancy S. Chung-Welch · Eagan, MNDirectorGregory S. St. Clair Sr · Eagan, MNDirectorBob I. Myers · Eagan, MNExecChuck S. Nuzum · Eagan, MNDirectorDavid Baker · Vancouver, British Columbia, CanadaExec · DirectorUlf Ek · London, United KingdomDirectorGreg Friedman · Atlanta, GADirectorMax Sharkansky · Miami Beach, FLDirectorDoug Flegg · Vancouver, British Columbia, CanadaDirectorMalcolm Frost · Indianapolis, INDirectorJ M. Engle · Eagan, MNDirectorZachary J. Schreiber · NEW YORK, NYExecJonathan R. Adler · Bethesda, MDDirectorMichael Christian · SEATTLE, WAExec · DirectorLavaca Convexity GP, LLC · Houston, TXDirectorMike Rice · Birmingham, ALDirectorGary King · Birmingham, ALDirectorChris Trotter · Birmingham, ALDirectorJ M. Engle · Eagan, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗